InvestorsHub Logo
Post# of 251813
Next 10
Followers 68
Posts 4505
Boards Moderated 0
Alias Born 12/13/2009

Re: DewDiligence post# 218580

Wednesday, 04/18/2018 5:13:46 PM

Wednesday, April 18, 2018 5:13:46 PM

Post# of 251813
Other 1st line ph3 trials mainly from melanoma and RCC, two indications traditionally are the most susceptible to immunotherapies.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.